🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study investigated a 4-week adjunctive therapy of either a GLP-1 analo...
Status
Completed
Location
Profil Institut für Stoffwechselforschung GmbH
Start Date
2008-01
Trial ID
NCT00971659
Extreme pediatric obesity, the fastest growing category of obesity in youth...
Status
Completed
Location
University of Minnesota
Start Date
2010-10
Trial ID
NCT01237197
This study is a placebo-controlled study in both healthy normal subjects an...
Status
Completed
Location
Multiple Locations
Start Date
2005-10
Trial ID
NCT00259896
Treatments Being Tested
The purpose of this substudy is to obtain CGM data from individuals taking ...
Status
Completed
Location
International Diabetes Center
Start Date
2006-12
Trial ID
NCT00803920
This study will look at the effect of exenatide, a drug which has been appr...
Status
Completed
Location
Beth Israel Deaconess Medical Center
Start Date
2007-04
Trial ID
NCT00456885
This study will compare the efficacy and safety of exenatide versus placebo...
Status
Completed
Location
Research Site
Start Date
2008-10
Trial ID
NCT00765817
This 3-arm study will assess the efficacy, safety and tolerability of taspo...
Status
Completed
Location
Multiple Locations
Start Date
2008-07
Trial ID
NCT00717457
Treatments Being Tested
This study will look at whether or not the medication exenatide improves si...
Status
Completed
Location
The University of Michigan Health System
Start Date
2008-06
Trial ID
NCT00855439
The purpose of this study is to determine the effect of GLP-1 receptor agon...
Status
Unknown
Location
First Hospital of Jilin University
Start Date
2017-02
Trial ID
NCT03018665
The study titled "Efficacy and Safety of Omarigliptin, A Weekly Dipeptidyl ...
Status
Unknown
Location
BIRDEM General Hospital
Start Date
2024-09
Trial ID
NCT06449235